aTyr Pharma, Inc.ATYRNASDAQ
Loading
Net Debt Over TimeElevated
Percentile Rank77
3Y CAGR-6.0%
Studio
Year-over-Year Change

Total debt minus cash and cash equivalents

3Y CAGR
-6.0%/yr
Annual compound
Percentile
P77
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
2025$1.29M-42.1%
2024$2.23M+129.9%
2023$-7.45M-579.7%
2022$1.55M+262.1%
2021$-958000.00+93.5%
2020$-14.71M-683.6%
2019$2.52M+136.4%
2018$-6.93M-409.7%
2017$-1.36M+95.3%
2016$-28.85M-